{"schema_version":"secwatch.filing_event.v1","accession":"0000785161-24-000034","form_type":"8-K","ticker":"EHC","cik":"0000785161","company_name":"Encompass Health Corp","filed_at":"2024-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.967471+00:00","generated_at":"2026-06-01T07:50:25.443197+00:00","sec_items":["7.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Encompass Health reaffirms FY2024 guidance: revenue $5.25B-$5.325B, Adj. EBITDA $1.03B-$1.065B, Adj. EPS $3.86-$4.11","bullets":["Reiterated full-year 2024 net operating revenue guidance of $5,250M to $5,325M.","Reaffirmed Adjusted EBITDA guidance of $1,030M to $1,065M for 2024.","Adjusted diluted EPS from continuing ops expected between $3.86 and $4.11.","Fireside chat at Leerink Partners Healthcare Crossroads Conference on May 30, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000785161-24-000034","json":"https://secwatch.observer/filing/0000785161-24-000034.json","markdown":"https://secwatch.observer/filing/0000785161-24-000034.md","text":"https://secwatch.observer/filing/0000785161-24-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/785161/000078516124000034/0000785161-24-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/785161/000078516124000034/ehc-20240529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:50:25.443197+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}